Small-Molecule Inhibitors of Dengue-Virus Entry

English version České info

Flavivirus envelope protein (E) mediates membrane fusion and viral entry from endosomes. A low-pH induced, dimer-to-trimer rearrangement and reconfiguration of the membrane-proximal “stem" of the E ectodomain draw together the viral and cellular membranes. We found stem-derived peptides from dengue virus (DV) bind stem-less E trimer and mimic the stem-reconfiguration step in the fusion pathway. We adapted this experiment as a high-throughput screen for small molecules that block peptide binding and thus may inhibit viral entry. A compound identified in this screen, 1662G07, and a number of its analogs reversibly inhibit DV infectivity. They do so by binding the prefusion, dimeric E on the virion surface, before adsorption to a cell. They also block viral fusion with liposomes. Structure-activity relationship studies have led to analogs with submicromolar IC₉₀s against DV2, and certain analogs are active against DV serotypes 1,2, and 4. The compounds do not inhibit the closely related Kunjin virus. We propose that they bind in a previously identified, E-protein pocket, exposed on the virion surface and although this pocket is closed in the postfusion trimer, its mouth is fully accessible. Examination of the E-trimer coordinates (PDB 1OK8) shows that conformational fluctuations around the hinge could open the pocket without dissociating the trimer or otherwise generating molecular collisions. We propose that compounds such as 1662G07 trap the sE trimer in a “pocket-open" state, which has lost affinity for the stem peptide and cannot support the final “zipping up" of the stem.

Vyšlo v časopise: Small-Molecule Inhibitors of Dengue-Virus Entry. PLoS Pathog 8(4): e32767. doi:10.1371/journal.ppat.1002627
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002627

Souhrn

Zdroje

1. HarrisonSC 2005 Mechanism of membrane fusion by viral envelope proteins. Adv Virus Res 64 231 261

2. HarrisonSC 2008 Viral membrane fusion. Nat Struct Mol Biol 15 690 698

3. van der SchaarHMRustMJChenCvan der Ende-MetselaarHWilschutJ 2008 Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4 e1000244

4. van der SchaarHMRustMJWaartsBLvan der Ende-MetselaarHKuhnRJ 2007 Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81 12019 12028

5. FritzRStiasnyKHeinzFX 2008 Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol 183 353 361

6. StiasnyKFritzRPangerlKHeinzFX 2011 Molecular mechanisms of flavivirus membrane fusion. Amino Acids 41 1159 1163

7. FerlenghiIClarkeMRuttanTAllisonSLSchalichJ 2001 Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell 7 593 602

8. BressanelliSStiasnyKAllisonSLSturaEADuquerroyS 2004 Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23 728 738

9. ModisYOgataSClementsDHarrisonSC 2003 A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100 6986 6991

10. ModisYOgataSClementsDHarrisonSC 2005 Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79 1223 1231

11. NayakVDessauMKuceraKAnthonyKLedizetM 2009 Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol 83 4338 4344

12. ReyFAHeinzFXMandlCKunzCHarrisonSC 1995 The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375 291 298

13. AllisonSLSchalichJStiasnyKMandlCWHeinzFX 2001 Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 75 4268 4275

14. KilbyJM 1999 Therapeutic potential of blocking HIV entry into cells: focus on membrane fusion inhibitors. Expert Opin Investig Drugs 8 1157 1170

15. KilbyJMHopkinsSVenettaTMDiMassimoBCloudGA 1998 Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 4 1302 1307

16. WildCGreenwellTMatthewsT 1993 A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res Hum Retroviruses 9 1051 1053

17. WildCOasTMcDanalCBolognesiDMatthewsT 1992 A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc Natl Acad Sci U S A 89 10537 10541

18. FreyGRits-VollochSZhangXQSchooleyRTChenB 2006 Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion. Proc Natl Acad Sci U S A 103 13938 13943

19. BonfantiJFRoymansD 2009 Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection. Curr Opin Drug Discov Devel 12 479 487

20. RoymansDDe BondtHLArnoultEGeluykensPGeversT 2010 Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein. Proc Natl Acad Sci U S A 107 308 313

21. LiaoMSanchez-San MartinCZhengAKielianM 2010 In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J Virol 84 5730 5740

22. Sanchez-San MartinCSosaHKielianM 2008 A stable prefusion intermediate of the alphavirus fusion protein reveals critical features of class II membrane fusion. Cell Host Microbe 4 600 608

23. SchmidtAGYangPLHarrisonSC 2010 Peptide inhibitors of flavivirus entry derived from the E protein stem. J Virol 84 12549 12554

24. SchmidtAGYangPLHarrisonSC 2010 Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 6 e1000851

25. ModisYOgataSClementsDHarrisonSC 2004 Structure of the dengue virus envelope protein after membrane fusion. Nature 427 313 319

26. ZhangWChipmanPRCorverJJohnsonPRZhangY 2003 Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 10 907 912

27. KampmannTYennamalliRCampbellPStoermerMJFairlieDP 2009 In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res 84 234 241

28. LiZKhaliqMZhouZPostCBKuhnRJ 2008 Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins. J Med Chem 51 4660 4671

29. WangQYPatelSJVangrevelingheEXuHYRaoR 2009 A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother 53 1823 1831

30. YennamalliRSubbaraoNKampmannTMcGearyRPYoungPR 2009 Identification of novel target sites and an inhibitor of the dengue virus E protein. J Comput Aided Mol Des 23 333 341

31. ZhouZKhaliqMSukJEPatkarCLiL 2008 Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. ACS Chem Biol 3 765 775

32. FriesnerRABanksJLMurphyRBHalgrenTAKlicicJJ 2004 Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J Med Chem 47 1739 1749

33. HassaneenH 2007 New Approach to 4- and 5-Aminopyrazole Derivatives. Synth Commun 37 3579 3588

34. PohMKYipAZhangSPriestleJPMaNL 2009 A small molecule fusion inhibitor of dengue virus. Antiviral Res 84 260 266